Table of Content

1 Rifaximin API Market Overview
1.1 Product Overview and Scope of Rifaximin API
1.2 Rifaximin API Segment by Type
1.2.1 Global Rifaximin API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 99% Purity
1.2.3 >99% Purity
1.3 Rifaximin API Segment by Application
1.3.1 Rifaximin API Sales Comparison by Application: (2021-2027)
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Rifaximin API Market Size Estimates and Forecasts
1.4.1 Global Rifaximin API Revenue 2016-2027
1.4.2 Global Rifaximin API Sales 2016-2027
1.4.3 Rifaximin API Market Size by Region: 2016 Versus 2021 Versus 2027

2 Rifaximin API Market Competition by Manufacturers
2.1 Global Rifaximin API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Rifaximin API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Rifaximin API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Rifaximin API Manufacturing Sites, Area Served, Product Type
2.5 Rifaximin API Market Competitive Situation and Trends
2.5.1 Rifaximin API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Rifaximin API Players Market Share by Revenue
2.5.3 Global Rifaximin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rifaximin API Retrospective Market Scenario by Region
3.1 Global Rifaximin API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Rifaximin API Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Rifaximin API Market Facts & Figures by Country
3.3.1 North America Rifaximin API Sales by Country
3.3.2 North America Rifaximin API Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rifaximin API Market Facts & Figures by Country
3.4.1 Europe Rifaximin API Sales by Country
3.4.2 Europe Rifaximin API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rifaximin API Market Facts & Figures by Region
3.5.1 Asia Pacific Rifaximin API Sales by Region
3.5.2 Asia Pacific Rifaximin API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Rifaximin API Market Facts & Figures by Country
3.6.1 Latin America Rifaximin API Sales by Country
3.6.2 Latin America Rifaximin API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Rifaximin API Market Facts & Figures by Country
3.7.1 Middle East and Africa Rifaximin API Sales by Country
3.7.2 Middle East and Africa Rifaximin API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Rifaximin API Historic Market Analysis by Type
4.1 Global Rifaximin API Sales Market Share by Type (2016-2021)
4.2 Global Rifaximin API Revenue Market Share by Type (2016-2021)
4.3 Global Rifaximin API Price by Type (2016-2021)

5 Global Rifaximin API Historic Market Analysis by Application
5.1 Global Rifaximin API Sales Market Share by Application (2016-2021)
5.2 Global Rifaximin API Revenue Market Share by Application (2016-2021)
5.3 Global Rifaximin API Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Salix Pharmaceuticals
6.1.1 Salix Pharmaceuticals Corporation Information
6.1.2 Salix Pharmaceuticals Description and Business Overview
6.1.3 Salix Pharmaceuticals Rifaximin API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Salix Pharmaceuticals Product Portfolio
6.1.5 Salix Pharmaceuticals Recent Developments/Updates
6.2 Lupin
6.2.1 Lupin Corporation Information
6.2.2 Lupin Description and Business Overview
6.2.3 Lupin Rifaximin API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Lupin Product Portfolio
6.2.5 Lupin Recent Developments/Updates
6.3 LGM Pharma
6.3.1 LGM Pharma Corporation Information
6.3.2 LGM Pharma Description and Business Overview
6.3.3 LGM Pharma Rifaximin API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 LGM Pharma Product Portfolio
6.3.5 LGM Pharma Recent Developments/Updates
6.4 B Joshi Agrochem Pharma
6.4.1 B Joshi Agrochem Pharma Corporation Information
6.4.2 B Joshi Agrochem Pharma Description and Business Overview
6.4.3 B Joshi Agrochem Pharma Rifaximin API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 B Joshi Agrochem Pharma Product Portfolio
6.4.5 B Joshi Agrochem Pharma Recent Developments/Updates
6.5 Triveni Interchem
6.5.1 Triveni Interchem Corporation Information
6.5.2 Triveni Interchem Description and Business Overview
6.5.3 Triveni Interchem Rifaximin API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Triveni Interchem Product Portfolio
6.5.5 Triveni Interchem Recent Developments/Updates

7 Rifaximin API Manufacturing Cost Analysis
7.1 Rifaximin API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rifaximin API
7.4 Rifaximin API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rifaximin API Distributors List
8.3 Rifaximin API Customers

9 Rifaximin API Market Dynamics
9.1 Rifaximin API Industry Trends
9.2 Rifaximin API Growth Drivers
9.3 Rifaximin API Market Challenges
9.4 Rifaximin API Market Restraints

10 Global Market Forecast
10.1 Rifaximin API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rifaximin API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Rifaximin API by Type (2022-2027)
10.2 Rifaximin API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rifaximin API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Rifaximin API by Application (2022-2027)
10.3 Rifaximin API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rifaximin API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Rifaximin API by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Rifaximin API Sales (Kiloton) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Rifaximin API Sales (Kiloton) Comparison by Application (2021-2027)
Table 3. Global Rifaximin API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Rifaximin API Covered in This Study
Table 5. Global Rifaximin API Sales (Kiloton) of Key Manufacturers (2016-2021)
Table 6. Global Rifaximin API Sales Share by Manufacturers (2016-2021)
Table 7. Global Rifaximin API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Rifaximin API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Rifaximin API Average Price (US$/Ton) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Rifaximin API Manufacturing Sites and Area Served
Table 11. Manufacturers Rifaximin API Product Type
Table 12. Global Rifaximin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Rifaximin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rifaximin API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Rifaximin API Sales by Region (2016-2021) & (Kiloton)
Table 16. Global Rifaximin API Sales Market Share by Region (2016-2021)
Table 17. Global Rifaximin API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Rifaximin API Sales by Country (2016-2021) & (Kiloton)
Table 19. North America Rifaximin API Sales Market Share by Country (2016-2021)
Table 20. North America Rifaximin API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Rifaximin API Revenue Market Share by Country (2016-2021)
Table 22. Europe Rifaximin API Sales by Country (2016-2021) & (Kiloton)
Table 23. Europe Rifaximin API Sales Market Share by Country (2016-2021)
Table 24. Europe Rifaximin API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Rifaximin API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Rifaximin API Sales by Region (2016-2021) & (Kiloton)
Table 27. Asia Pacific Rifaximin API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Rifaximin API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Rifaximin API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Rifaximin API Sales by Country (2016-2021) & (Kiloton)
Table 31. Latin America Rifaximin API Sales Market Share by Country (2016-2021)
Table 32. Latin America Rifaximin API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Rifaximin API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Rifaximin API Sales by Country (2016-2021) & (Kiloton)
Table 35. Middle East and Africa Rifaximin API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Rifaximin API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Rifaximin API Revenue Market Share by Country (2016-2021)
Table 38. Global Rifaximin API Sales (Kiloton) by Type (2016-2021)
Table 39. Global Rifaximin API Sales Market Share by Type (2016-2021)
Table 40. Global Rifaximin API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Rifaximin API Revenue Share by Type (2016-2021)
Table 42. Global Rifaximin API Price (US$/Ton) by Type (2016-2021)
Table 43. Global Rifaximin API Sales (Kiloton) by Application (2016-2021)
Table 44. Global Rifaximin API Sales Market Share by Application (2016-2021)
Table 45. Global Rifaximin API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Rifaximin API Revenue Share by Application (2016-2021)
Table 47. Global Rifaximin API Price (US$/Ton) by Application (2016-2021)
Table 48. Salix Pharmaceuticals Corporation Information
Table 49. Salix Pharmaceuticals Description and Business Overview
Table 50. Salix Pharmaceuticals Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 51. Salix Pharmaceuticals Rifaximin API Product
Table 52. Salix Pharmaceuticals Recent Developments/Updates
Table 53. Lupin Corporation Information
Table 54. Lupin Description and Business Overview
Table 55. Lupin Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 56. Lupin Rifaximin API Product
Table 57. Lupin Recent Developments/Updates
Table 58. LGM Pharma Corporation Information
Table 59. LGM Pharma Description and Business Overview
Table 60. LGM Pharma Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 61. LGM Pharma Rifaximin API Product
Table 62. LGM Pharma Recent Developments/Updates
Table 63. B Joshi Agrochem Pharma Corporation Information
Table 64. B Joshi Agrochem Pharma Description and Business Overview
Table 65. B Joshi Agrochem Pharma Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 66. B Joshi Agrochem Pharma Rifaximin API Product
Table 67. B Joshi Agrochem Pharma Recent Developments/Updates
Table 68. Triveni Interchem Corporation Information
Table 69. Triveni Interchem Description and Business Overview
Table 70. Triveni Interchem Rifaximin API Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 71. Triveni Interchem Rifaximin API Product
Table 72. Triveni Interchem Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Rifaximin API Distributors List
Table 76. Rifaximin API Customers List
Table 77. Rifaximin API Market Trends
Table 78. Rifaximin API Growth Drivers
Table 79. Rifaximin API Market Restraints
Table 80. Global Rifaximin API Sales Forecast by Type (2022-2027) & (Kiloton)
Table 81. Global Rifaximin API Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Rifaximin API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Rifaximin API Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Rifaximin API Sales Forecast by Application (2022-2027) & (Kiloton)
Table 85. Global Rifaximin API Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Rifaximin API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Rifaximin API Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Rifaximin API Sales Forecast by Region (2022-2027) & (Kiloton)
Table 89. Global Rifaximin API Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Rifaximin API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Rifaximin API Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rifaximin API
Figure 2. Global Rifaximin API Market Share by Type in 2020 & 2027
Figure 3. 99% Purity Product Picture
Figure 4. >99% Purity Product Picture
Figure 5. Global Rifaximin API Market Share by Application in 2020 & 2027
Figure 6. Pharmaceuticals
Figure 7. Others
Figure 8. Global Rifaximin API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Rifaximin API Market Size 2016-2027 (US$ Million)
Figure 10. Global Rifaximin API Sales 2016-2027 (Kiloton)
Figure 11. Global Rifaximin API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Rifaximin API Sales Share by Manufacturers in 2020
Figure 13. Global Rifaximin API Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Rifaximin API Players: Market Share by Revenue in 2020
Figure 15. Rifaximin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Rifaximin API Sales Market Share by Region (2016-2021)
Figure 17. Global Rifaximin API Sales Market Share by Region in 2020
Figure 18. Global Rifaximin API Revenue Market Share by Region (2016-2021)
Figure 19. Global Rifaximin API Revenue Market Share by Region in 2020
Figure 20. U.S. Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Rifaximin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Rifaximin API by Type (2016-2021)
Figure 45. Sales Market Share of Rifaximin API by Application (2016-2021)
Figure 46. Sales Market Share of Rifaximin API by Application in 2020
Figure 47. Revenue Share of Rifaximin API by Application (2016-2021)
Figure 48. Revenue Share of Rifaximin API by Application in 2020
Figure 49. Manufacturing Cost Structure of Rifaximin API
Figure 50. Manufacturing Process Analysis of Rifaximin API
Figure 51. Rifaximin API Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed